Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 16/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5840574 | 0.91 | PDE4B (0.49) | PDE4BPDE4APDE4DCYP3A4 | |
| SCHEMBL5841979 | 0.91 | PDE4B (0.49) | PDE4BPDE4APDE4DCYP3A4 | |
| SCHEMBL5840576 | 0.91 | PDE4B (0.49) | PDE4BPDE4APDE4DCYP3A4 | |
| SCHEMBL5776945 | 0.85 | PDE4B (0.51) | PDE4BPDE4APDE4DCYP3A4 | |
| SCHEMBL5776940 | 0.85 | PDE4B (0.51) | PDE4BPDE4APDE4DCYP3A4 | |
| SCHEMBL5844771 | 0.83 | PDE4B (0.50) | PDE4BPDE4APDE4D | |
| SCHEMBL5844767 | 0.83 | PDE4B (0.50) | PDE4BPDE4APDE4D | |
| SCHEMBL8314996 | 0.83 | PTGER4 (0.39) | PDE4BPDE4APDE4DPTGER4CYP3A4 | |
| SCHEMBL5840369 | 0.81 | PDE4B (0.51) | PDE4BPDE4APDE4DCYP3A4 | |
| SCHEMBL5840361 | 0.81 | PDE4B (0.51) | PDE4BPDE4APDE4DCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005009966-A1 | NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS | PFIZER LIMITED (GB) | 2005-02-03 | — | — | WO | disclosed |